|
| Figure 7: Consumption of StemEnhance triggered a transient increase in the number of circulating CD34+ cells that peaked at 60 min after consumption (25±1%). The data shown are the averages of changes within each group and were calculated in the following manner: the actual numbers of CD34+ cells were calculated by multiplying the percent CD34+ cells, based on immunostaining and flow cytometry on triplicate samples from each sampling time point, by the number of lymphocytes, as obtained by CBC, also performed in triplicate for each sampling time point, normalized to the value 1.0 at time 0 (immediately prior to consumption). The fines connecting each data set do not indicate a linear function but only serve to indicate which data sets belong to each treatment. |
